Jump to content

Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Targeting Focal Adhesion Kinase (FAK) in Fibrotic Diseases.

  • Please log in to reply
No replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,559 posts
  • Location:West Sussex

Posted 21 February 2013 - 02:17 PM

Targeting Focal Adhesion Kinase (FAK) in Fibrotic Diseases.

Recent findings suggest that FAK plays a key role in development offibrotic disorders, and it appears to be an attractive target forantifibrotic therapy and has potential as a future therapeutic target to
counteract fibrosis. PubMed, BioDrugs. 2012 Nov 27. (Also see: Pulmonary Fibrosis Research)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)